Inovio Pharmaceuticals Inc
NASDAQ:INO
Inovio Pharmaceuticals Inc
NASDAQ:INO
Price:
1.16
USD
1.75%
Market Closed
Market Cap:
$95.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Inovio Pharmaceuticals Inc
NASDAQ:INO
|
US |
|
S
|
SEB SA
XBER:GRB
|
FR |
|
Distribuidora Internacional de Alimentacion SA
MAD:DIA
|
ES |
|
NAPCO Security Technologies Inc
NASDAQ:NSSC
|
US |
|
Computer Modelling Group Ltd
TSX:CMG
|
CA |
|
Aurania Resources Ltd
XTSX:ARU
|
CA |
|
S
|
Seagate Technology Holdings PLC
XBER:847
|
SG |
|
Zebra Technologies Corp
NASDAQ:ZBRA
|
US |
|
G
|
Gulf Energy Development PCL
SET:GULF
|
TH |
|
M
|
Marqeta Inc
NASDAQ:MQ
|
US |
|
Eastone Century Technology Co Ltd
SZSE:300310
|
CN |
|
Schindler Holding AG
SIX:SCHP
|
CH |
|
W
|
Westports Holdings Bhd
KLSE:WPRTS
|
MY |
|
Eiffage SA
PAR:FGR
|
FR |
|
Cibox Inter@ctive SA
PAR:ALCBX
|
FR |
|
F
|
F-Secure Oyj
OMXH:FSECURE
|
FI |
Wall St Price Targets
INO Price Targets Summary
Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc
Wall Street analysts forecast INO stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for INO is 6.9 USD with a low forecast of 1.82 USD and a high forecast of 13.65 USD.
Lowest Forecast
Price Target
1.82
USD
57% Upside
Average Forecast
Price Target
6.9
USD
494% Upside
Highest Forecast
Price Target
13.65
USD
1 077% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is INO's stock price target?
Price Target
6.9
USD
6.9
USD
According to Wall Street analysts, the average 1-year price target for INO is 6.9 USD with a low forecast of 1.82 USD and a high forecast of 13.65 USD.
What is the Revenue forecast for Inovio Pharmaceuticals Inc?
Projected CAGR
181%
181%
Over the last 14 years, the compound annual growth rate for Revenue has been -30%. The projected CAGR for the next 8 years is 181%.
